IdentificationGeneric Name(1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetateDrugBank Accession NumberDB08497BackgroundNot AvailableTypeSmall MoleculeGroupsExperimentalStructure


3DDownload MOLSDF3D-SDFPDBSMILESInChI


 Similar StructuresStructure for (1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate (DB08497)× CloseWeightAverage: 366.3243 Monoisotopic: 366.08518619 Chemical FormulaC19H14N2O6SynonymsNot AvailablePharmacologyIndicationNot AvailableReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See howContraindications & Blackbox WarningsAvoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events & improve clinical decision support.Learn morePharmacodynamicsNot AvailableMechanism of actionTargetActionsOrganismUCaspase-3Not AvailableHumansAbsorptionNot AvailableVolume of distributionNot AvailableProtein bindingNot AvailableMetabolismNot AvailableRoute of eliminationNot AvailableHalf-lifeNot AvailableClearanceNot AvailableAdverse EffectsImprove decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Learn more  Improve decision support & research outcomes with our structured adverse effects data.Learn moreToxicityNot AvailablePathwaysNot AvailablePharmacogenomic Effects/ADRs 


Not AvailableInteractionsDrug Interactions 


This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not AvailableFood InteractionsNot AvailableCategoriesDrug CategoriesNot AvailableChemical TaxonomyProvided by ClassyfireDescriptionThis compound belongs to the class of organic compounds known as 1,4-isoquinolinediones. These are isoquinoline derivatives carrying a C=O group at positions 1 and 4, respectively.KingdomOrganic compoundsSuper ClassOrganoheterocyclic compoundsClassIsoquinolines and derivativesSub Class1,4-isoquinolinedionesDirect Parent1,4-isoquinolinedionesAlternative Parents1,3-isoquinolinediones / Isoquinolones and derivatives / Tetrahydroisoquinolines / Phenylacetamides / Benzyloxycarbonyls / Aryl ketones / N-arylamides / Vinylogous amides / N-unsubstituted carboxylic acid imides / Dicarboximides / Secondary carboxylic acid amides / Carboxylic acid esters / Azacyclic compounds / Monocarboxylic acids and derivatives / Organopnictogen compounds / Organic oxides / Hydrocarbon derivatives


 show 7 moreSubstituents1,3-isoquinolinedione / 2,3-dihydroisoquinoline-1,4-dione / Aromatic heteropolycyclic compound / Aryl ketone / Azacycle / Benzenoid / Benzyloxycarbonyl / Carbonyl group / Carboxamide group / Carboxylic acid derivative / Carboxylic acid ester / Carboxylic acid imide / Carboxylic acid imide, n-unsubstituted / Dicarboximide / Hydrocarbon derivative / Isoquinolone / Ketone / Monocarboxylic acid or derivatives / Monocyclic benzene moiety / N-arylamide / Organic nitrogen compound / Organic oxide / Organic oxygen compound / Organonitrogen compound / Organooxygen compound / Organopnictogen compound / Phenylacetamide / Secondary carboxylic acid amide / Tetrahydroisoquinoline / Vinylogous amide


 show 20 moreMolecular FrameworkAromatic heteropolycyclic compoundsExternal DescriptorsNot AvailableAffected organismsNot AvailableChemical IdentifiersUNIINot AvailableCAS numberNot AvailableInChI KeyNKBDSMREMMRFSI-INIZCTEOSA-NInChIInChI=1S/C19H14N2O6/c1-10(22)27-16(11-6-3-2-4-7-11)19(26)20-13-9-5-8-12-14(13)15(23)18(25)21-17(12)24/h2-9,16H,1H3,(H,20,26)(H,21,24,25)/t16-/m0/s1IUPAC Name(S)-phenyl[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)carbamoyl]methyl acetateSMILES[H][C@@](OC(C)=O)(C(=O)NC1=CC=CC2=C1C(=O)C(=O)NC2=O)C1=CC=CC=C1ReferencesGeneral ReferencesNot AvailableExternal LinksPubChem Compound24883486PubChem Substance99444968ChemSpider25058806ZINCZINC000013683220PDBe LigandRXBPDB Entries3deiClinical TrialsClinical Trials 


PhaseStatusPurposeConditionsCountPharmacoeconomicsManufacturersNot AvailablePackagersNot AvailableDosage FormsNot AvailablePricesNot AvailablePatentsNot AvailablePropertiesStateSolidExperimental PropertiesNot AvailablePredicted PropertiesPropertyValueSourceWater Solubility0.0126 mg/mLALOGPSlogP1.91ALOGPSlogP2ChemaxonlogS-4.5ALOGPSpKa (Strongest Acidic)5.51ChemaxonpKa (Strongest Basic)-7ChemaxonPhysiological Charge-1ChemaxonHydrogen Acceptor Count5ChemaxonHydrogen Donor Count2ChemaxonPolar Surface Area118.64 Å2ChemaxonRotatable Bond Count5ChemaxonRefractivity94.33 m3·mol-1ChemaxonPolarizability34.93 Å3ChemaxonNumber of Rings3ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterYesChemaxonVeber's RuleNoChemaxonMDDR-like RuleNoChemaxonPredicted ADMET FeaturesPropertyValueProbabilityHuman Intestinal Absorption+0.8981Blood Brain Barrier+0.6862Caco-2 permeable-0.5616P-glycoprotein substrateNon-substrate0.5461P-glycoprotein inhibitor IInhibitor0.5079P-glycoprotein inhibitor IINon-inhibitor0.5154Renal organic cation transporterNon-inhibitor0.9448CYP450 2C9 substrateNon-substrate0.7817CYP450 2D6 substrateNon-substrate0.8666CYP450 3A4 substrateNon-substrate0.5528CYP450 1A2 substrateInhibitor0.5841CYP450 2C9 inhibitorNon-inhibitor0.6309CYP450 2D6 inhibitorNon-inhibitor0.9447CYP450 2C19 inhibitorNon-inhibitor0.7158CYP450 3A4 inhibitorNon-inhibitor0.8107CYP450 inhibitory promiscuityHigh CYP Inhibitory Promiscuity0.5Ames testNon AMES toxic0.7246CarcinogenicityNon-carcinogens0.9046BiodegradationNot ready biodegradable0.9138Rat acute toxicity2.0537 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.9938hERG inhibition (predictor II)Non-inhibitor0.863  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397) SpectraMass Spec (NIST)Not AvailableSpectraSpectrumSpectrum TypeSplash KeyPredicted GC-MS Spectrum - GC-MSPredicted GC-MSNot AvailablePredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot AvailableTargetsBuild, predict & validate machine-learning modelsUse our structured and evidence-based datasets to unlock newinsights and accelerate drug research.Learn more  Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.Learn more


 Details1. Caspase-3KindProteinOrganismHumansPharmacological actionUnknownGeneral FunctionPhospholipase a2 activator activitySpecific FunctionInvolved in the activation cascade of caspases responsible for apoptosis execution. At the onset of apoptosis it proteolytically cleaves poly(ADP-ribose) polymerase (PARP) at a '216-Asp-|-Gly-217' ...Gene NameCASP3Uniprot IDP42574Uniprot NameCaspase-3Molecular Weight31607.58 DaReferencesBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article] ×Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   Drug created at September 15, 2010 21:32 / Updated at June 12, 2020 16:52 